Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |